The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-Amino-2-[(9-mercaptomethyl-10-oxo-azecane-2-carbonyl)-amino]-hexanoic acid hydrochloride ID: ALA555862
PubChem CID: 44349893
Max Phase: Preclinical
Molecular Formula: C17H32ClN3O4S
Molecular Weight: 373.52
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cl.NCCCC[C@@H](NC(=O)C1CCCCCCC(CS)C(=O)N1)C(=O)O
Standard InChI: InChI=1S/C17H31N3O4S.ClH/c18-10-6-5-9-14(17(23)24)20-16(22)13-8-4-2-1-3-7-12(11-25)15(21)19-13;/h12-14,25H,1-11,18H2,(H,19,21)(H,20,22)(H,23,24);1H/t12?,13?,14-;/m1./s1
Standard InChI Key: UWCHZBLBKKUVFU-YLIRPONSSA-N
Molfile:
RDKit 2D
26 25 0 0 0 0 0 0 0 0999 V2000
7.7125 -2.4125 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
4.2125 -1.8000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6917 -2.1000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7167 -2.7000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2417 -3.0000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.7167 -2.1000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1792 -1.8000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7167 -3.9000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2375 -3.6000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6875 -2.7000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2000 -2.9917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2000 -3.5917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.7125 -4.5000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1292 -1.7917 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.6542 -2.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7917 -3.9042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1792 -1.2000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2417 -1.8000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7542 -3.9000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7917 -4.5042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7542 -4.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2667 -4.8000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6917 -0.9000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2500 -1.2000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7292 -0.9000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2125 -1.2000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3 2 1 0
4 6 1 0
5 4 1 0
6 2 1 0
7 3 1 0
9 8 1 6
9 5 1 0
10 3 2 0
11 4 2 0
12 8 2 0
13 8 1 0
14 15 1 0
15 7 1 0
16 20 1 0
17 7 1 0
18 6 1 0
19 9 1 0
20 22 1 0
21 19 1 0
22 21 1 0
23 17 1 0
24 18 1 0
25 24 1 0
26 25 1 0
23 26 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 373.52Molecular Weight (Monoisotopic): 373.2035AlogP: 1.07#Rotatable Bonds: 8Polar Surface Area: 121.52Molecular Species: ZWITTERIONHBA: 5HBD: 5#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.83CX Basic pKa: 10.44CX LogP: -1.08CX LogD: -1.09Aromatic Rings: ┄Heavy Atoms: 25QED Weighted: 0.32Np Likeness Score: 0.48
References 1. MacPherson LJ, Bayburt EK, Capparelli MP, Bohacek RS, Clarke FH, Ghai RD, Sakane Y, Berry CJ, Peppard JV, Trapani AJ.. (1993) Design and synthesis of an orally active macrocyclic neutral endopeptidase 24.11 inhibitor., 36 (24): [PMID:8254611 ] [10.1021/jm00076a009 ]